Journal profile · BIOTECHNOLOGY & APPLIED MICROBIOLOGY
Bioengineered
ISSN 2165-5979 · eISSN 2165-5987 · Taylor and Francis Ltd. · UNITED STATES
Bioengineered: CAS Zone 4 · Biology (2025 upgraded edition); impact factor 9.04; fully open access; APC about USD 2,864; median 180 days to acceptance (12 articles, last 24 months); acceptance rate 20% (journal website); 33 articles in 2025; indexed in Scopus; flagged on an early-warning list or for an indexing change: check before submitting.
Scope
Aims, scope and focus
Bioengineered is published by Taylor and Francis Ltd. and is in Zone 4 of Biology in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Cancer-related molecular mechanisms research, MicroRNA in disease regulation and Circular RNAs in diseases, together about 54.4% of its articles. Its main subfields are Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
Bioengineered is a fully open access, multi-disciplinary journal covering bioengineering and biotechnology, focusing on fundamental and advance sciences. The journal welcomes manuscripts with a techno-socio-economic focus on the use of biotechnology for food, pharmaceutical and industrial applications, and its use in bioprocesses, bioproducts, conversion technologies, sustainable biological recycling and the recovery of environmental resources. Topics covered in Bioengineered include: Bioenergy, biofuels and biodefense Bioengineered therapeutics, devices and drug delivery Biomaterials,biomolecules and Bioprocesses of organic resources Bioremediation, biodegradation, and bioaccumulation Biorefinery Cellular engineering Fate of biological pollutants in the environment Genetic and Molecular Engineering Systems and Synthetic Bioengineering Computational Bioengineering Bioengineered welcomes submissions of original research, reviews, and comments on the latest advances and issues across the field. The journal operates a single anonymous peer review policy.
From the journal's Aims & Scope
Research area (LetPub): BIOTECHNOLOGY & APPLIED MICROBIOLOGY
Editor-in-chief Jelena ViderPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Cancer-related molecular mechanisms researchBiochemistry, Genetics and Molecular Biology21.2%
- MicroRNA in disease regulationBiochemistry, Genetics and Molecular Biology17.1%
- Circular RNAs in diseasesBiochemistry, Genetics and Molecular Biology16.1%
- RNA modifications and cancerBiochemistry, Genetics and Molecular Biology9%
- Ferroptosis and cancer prognosisMedicine3.8%
- RNA Research and SplicingBiochemistry, Genetics and Molecular Biology3.4%
- Microbial Metabolic Engineering and BioproductionBiochemistry, Genetics and Molecular Biology3.2%
- Biofuel production and bioconversionEngineering2.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Biology Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 4 |
| Minor | Biotechnology & Applied Microbiology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Biology Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 4 |
| Minor | Biotechnology & Applied Microbiology | Zone 4 |
Top journal: noReview journal: no
JCR / CiteScore quartiles on the journal's website
- CiteScore Q1 · 2025
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
ScopusLetPub
Early warning / risk: Removed from SCIE for editorial reasons on 22 April 2025. CAS Early Warning Journal List: listed in the 2024 edition (paper mill); not listed in the other 5 editions.LetPub
Indexing the journal's website claims
MEDLINEPMCEmbaseCAB AbstractsPublisher website
Other: EBSCO, Biological Abstracts
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 9.04LetPub ·
- CiteScore 2026-06
- 15.4LetPub ·
- CiteScore (publisher) 2025
- 15.4Publisher website ·
- SJR 2026-06
- 1.02LetPub ·
- SJR (publisher) 2025
- 1.02Publisher website ·
- SNIP 2026-06
- 1.02LetPub ·
- SNIP (publisher) 2025
- 1.02Publisher website ·
- h-index
- 26LetPub ·
- h-index
- 87OpenAlex ·
- i10-index
- 2,115OpenAlex ·
- 2-year mean citedness
- 2.23OpenAlex ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 51LetPub ·
- Downloads per year (publisher)
- 1,300,000Publisher website ·
Articles by year OpenAlex count · 3,055 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 47 | 47 | 0 |
| 2025 | 33 | 33 | 117 |
| 2024 | 80 | 80 | 239 |
| 2023 | 63 | 63 | 1,753 |
| 2022 | 1,037 | 1,037 | 20,304 |
| 2021 | 1,098 | 1,098 | 25,425 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
180 daysMedian, submission to acceptance · P25–P75 120 days – 237 days
- Acceptance to online
- median 66 days (12 articles)
- Submission to online
- median 231 days
- Sample
- 12 articles with submission and acceptance dates (120 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 17 weeksLetPub ·
- Acceptance rate (publisher)
- 20%Publisher website ·
- Peer review
- Anonymous peer reviewLetPub
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessOpenAlex
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | GBP 2,335 | — | — | |
| LetPub | EUR 2,875 / USD 2,990 / GBP 2,392 | Yes | — | |
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted3
- expression of concernExpression of ConcernLength not stated
- research articleResearch ArticleLength not stated
- review articleReview ArticleLength not stated
Policy excerpts from the journal's websiteOpen access, Peer review
- Open access Open access
open access Model summary
Bioengineered is an open access journal and only publishes open access articles. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research. Why choose open access? Increase the discoverability and readership of your article Make an impact and reach new readers, not just those with easy…
Source ↗Publisher website ·- Peer review
single anonymous peer review Model summary
The journal operates a single anonymous peer review policy.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Taylor and Francis Ltd.
- Country or region
- UNITED STATES
- Language
- English
- ISSN
- 2165-5979
- Electronic ISSN
- 2165-5987
- Latest issue on the website
- Volume 17, Issue 1 (2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- Peer review process ↗LetPub
- Editorial board ↗LetPub
FAQ
Frequently asked questions about Bioengineered
What CAS zone is Bioengineered in?
In the 2025 upgraded edition of the CAS Journal Ranking, Bioengineered is in Zone 4 of Biology, and in Zone 4 of the minor category Biotechnology & Applied Microbiology. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Bioengineered?
The latest impact factor listed by LetPub is 9.04; CiteScore 15.4, h-index 87.
How long does peer review take at Bioengineered?
Based on the dates recorded on 12 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 180 days (interquartile range 120–237 days); authors report an average review time of about 17 weeks; the journal's website gives an acceptance rate of 20%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Bioengineered?
According to LetPub and DOAJ records, Bioengineered is indexed in Scopus. The journal's website also lists MEDLINE, PMC, Embase and CAB Abstracts; that list has not been checked against each database.
Is Bioengineered open access, and what is the APC?
Bioengineered is a fully open-access journal. APC about USD 2,864.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .